(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/crwe_tech.jpg

Your Technology Source, Your Technology Team

Server Maintenance, Web Development, Mobile Application Solutions, SEO Services and more

Contact Us: contact@crwetech.com

www.CRWETech.com

ad2

http://crweworld.com/assets/images/ad/ad4.png

Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com

www.CRWEWorld.com

ad3

http://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

http://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com

ad5

http://crweworld.com/assets/images/ad/Pathology_Laboratories.png

Quest Diagnostics Inc. (NYSE:DGX) offers the most extensive clinical testing network in the U.S. The Company's extensive test menu includes routine biological testing; complex and specialized molecular and gene-based testing, and anatomic pathology testing. These services primarily help identify disease or risk factors for disease and predict and monitor response to treatment.

www.QuestDiagnostics.com






Latest News Releases From The Newsroom

xG Technology Signs Final Definitive Business Purchase Agreement to Acquire Vislink Communication Systems

December 19th, 2016

Sarasota, Florida / CRWE PRESS RELEASE / December 19, 2016 - xG Technology, Inc. (“xG”) (Nasdaq: XGTI, XGTIW), a leader in providing critical wireless communications for use in challenging operating environments, is pleased to announ. Read more

Uranium Resources Signs Binding Amendment for Sale of Assets

December 14th, 2016

CENTENNIAL, Colo. / CRWE PRESS RELEASE / December 14, 2016 - Uranium Resources, Inc. (Nasdaq: URRE; ASX: URI), an energy metals exploration and development company, has entered into a binding amendment to the Share Purchase Agreement (“Agreemen. Read more

Bombardier Announces 2017 Guidance, Targeting Strong Earnings Growth and FCF Improvement

December 14th, 2016

* Targets EBIT growth before special items(1) of approximately 50%, to $530 million - $630 million * Anticipates year-over-year free cash flow usage(1) improvement by approximately $400 million, to $750 million - $1.0 billion * Expects low sing. Read more

vTv Therapeutics Announces Positive Topline Results from Phase 2 Study of TTP273 in Type 2 Diabetes

December 14th, 2016

Oral small molecule GLP-1 receptor agonist met primary endpoint Company’s second successful Phase 2 diabetes trial in 2016 High Point, North Carolina / CRWE PRESS RELEASE / December 14, 2016 - vTv Therapeutics Inc. (vTv) (Nasdaq: VTVT) to. Read more

Teck Announces USD$285 Q1 Coal Benchmark and Collective Agreements at Elkview and Fording River

December 12th, 2016

Vancouver, B.C. / CRWE PRESS RELEASE / December 12, 2016 – Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) today announced that it has settled with major customers a benchmark price for the first quarter of. Read more

Bombardier to Hold Investor Day

December 10th, 2016

Montréal, Québec / CRWE PRESS RELEASE / December 9, 2016 - Bombardier (TSX:BBD.A)(TSX:BBD.B)(OTCQX:BDRBF) will hold an Investor Day in New York City on Thursday, December 15, 2016 for investors and financial analysts. This will be an. Read more

Anavex Life Sciences Announces 12-Month Data of ANAVEX 2-73 in a Phase 2a Study in Mild-to-Moderate Alzheimer's Disease Patients

December 08th, 2016

Data presentation at CTAD 2016 NEW YORK, NY / CRWE PRESS RELEASE / December 8, 2016 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL) today announced a positive 57-week update from its . Read more

Philippine Airlines and Bombardier Finalize Order for up to 12 Q400 Aircraft

December 08th, 2016

Order confirms airline as launch customer of two-class, 86-seat Q400 aircraft Montréal, Québec / CRWE PRESS RELEASE / December 8, 2016 - Bombardier Commercial Aircraft announced today that it has finalized a firm purchase agreement w. Read more

Puma Biotechnology Presents Results of Biomarker Analysis of Phase II Trial of PB272 in Neoadjuvant Treatment of HER2-Positive Locally Advanced Breast Cancer at the 2016 San Antonio Breast Cancer Symposium

December 07th, 2016

LOS ANGELES, Calif. / CRWE PRESS RELEASE / December 7, 2016 - Puma Biotechnology, Inc. (NYSE: PBYI), a biopharmaceutical company, announced that a biomarker analysis of the NSABP FB-7 Phase II clinical trial of Puma's investigational drug PB. Read more

Puma Biotechnology Presents Interim Results of Phase II Trial of PB272 for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2016 San Antonio Breast Cancer Symposium

December 07th, 2016

LOS ANGELES, Calif. / CRWE PRESS RELEASE / December 7, 2016 - Puma Biotechnology, Inc. (NYSE: PBYI), a biopharmaceutical company, announced that updated interim results from an ongoing Phase II clinical trial of Puma's investigational drug P. Read more